Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q2 FY20 results · Jul–Sep 2019
Camlin Fine Sciences reported revenue from operations of ₹222.28 crore (up 10.4% from Q2 FY19) and net profit of ₹7.52 crore (up 290.3% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 222.28 | 201.34 | +10.4% | 260.12 | −14.5% |
| Other income | 0.64 | 9.88 | −93.5% | 0.65 | −1.9% |
| Total income | 222.92 | 211.22 | +5.5% | 260.78 | −14.5% |
| Profit before tax | 8.56 | 9.97 | −14.2% | 22.68 | −62.3% |
| Net profit for the period | 7.52 | 1.93 | +290.3% | 16.43 | −54.2% |
| Attributable to shareholders of the company | 6.94 | 1.31 | +430.7% | 15.56 | −55.4% |
| EPS, basic (₹) | 0.57 | 0.11 | +418.2% | 1.28 | −55.5% |
| Net margin (%) | 3.4 | 1.0 | 6.3 |
Consolidated
- Filed with BSE
- 14 Nov 2019, 16:05 IST
- Board meeting
- 08 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE